Evidence map›Paper›PMID 40772786›Full record

ReviewJournal of clinical microbiology2025

Overview of changes in the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: M100 32nd and 33rd editions.

Audrey N Schuetz, Andrea Ferrell, Janet A Hindler, Romney Humphries, April M Bobenchik

Abstract readReview
In one paragraph

Review in Journal of clinical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Genomic diversity and topical antimicrobial resistance inAntimicrobial agents and chemotherapy · 2026
    Article
  12. Molecular epidemiology ofMicrobiology spectrum · 2026
    Article
  13. Article
  14. FirstMicrobiology spectrum · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Audrey N SchuetzDepartment of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.ORCID 0000-0002-5837-270X
Andrea FerrellR&D, BD Life Sciences, Sparks, Maryland, USA.ORCID 0009-0002-2012-0141
Janet A HindlerPublic Health Laboratories, Los Angeles County Department of Public Health, Los Angeles, California, USA.
Romney HumphriesDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-6568-156X
April M BobenchikDepartment of Pathology and Laboratory Medicine, Penn State Hershey Medical Center, Hershey, Pennsylvania, USA.ORCID 0009-0008-6167-198X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing (AST) publishes annual updates to the M100

Indexed as

Anti-Bacterial AgentsDrug Resistance, Multiple, BacterialGram-Negative BacteriaGram-Positive BacteriaHumansMicrobial Sensitivity TestsQuality ControlAnti-Bacterial Agentsantibioticantimicrobial agentsbreakpointsCLSIdisk diffusionKirby-BauerM100minimal inhibitory concentrationquality controlsusceptibility testing

Identifiers

PMID40772786
PMCPMC12421849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.